Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Cardiff Oncology Inc (CRDF)

Cardiff Oncology Inc (CRDF)
2.70 x 7 2.96 x 5
Pre-market by (Cboe BZX)
2.69 -0.06 (-2.18%) 04/07/25 [NASDAQ]
2.70 x 7 2.96 x 5
Pre-market 2.69 unch (unch) 05:48 ET
News & Headlines for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

/CNW/ -- As the global cancer crisis intensifies, the demand for breakthrough treatments is reaching new heights. Statista data projects a 20% rise in annual...

ONCY : 0.5276 (+6.54%)
EXEL : 34.84 (+0.78%)
ONC.TO : 0.79 (+12.86%)
ALXO : 0.5353 (+3.76%)
CRDF : 2.69 (-2.18%)
VSTM : 5.10 (-1.16%)
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

CRDF : 2.69 (-2.18%)
Cardiff Oncology to Present at Upcoming Investor Conferences

CRDF : 2.69 (-2.18%)
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

CRDF : 2.69 (-2.18%)
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END

ONCY : 0.5276 (+6.54%)
AZN : 65.79 (-3.90%)
ABBV : 186.55 (-0.22%)
ONC.TO : 0.79 (+12.86%)
GSK : 34.84 (-4.63%)
CRDF : 2.69 (-2.18%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.5276 (+6.54%)
CKPT : 3.99 (-0.50%)
PSNL : 3.25 (+4.50%)
ONC.TO : 0.79 (+12.86%)
TEM : 42.70 (+0.28%)
CRDF : 2.69 (-2.18%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.5276 (+6.54%)
CKPT : 3.99 (-0.50%)
PSNL : 3.25 (+4.50%)
ONC.TO : 0.79 (+12.86%)
TEM : 42.70 (+0.28%)
CRDF : 2.69 (-2.18%)
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments

/CNW/ -- USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...

ONCY : 0.5276 (+6.54%)
CKPT : 3.99 (-0.50%)
LLY : 723.73 (-1.96%)
ONC.TO : 0.79 (+12.86%)
OSTX : 1.4300 (+2.14%)
CRDF : 2.69 (-2.18%)
Cardiff Oncology Reports Promising Initial Results from Phase 2 CRDF-004 Trial of Onvansertib in RAS-Mutated mCRC

Cardiff Oncology's Phase 2 trial shows onvansertib combined with SoC yields 64% ORR in RAS-mut mCRC patients.Quiver AI SummaryCardiff Oncology, Inc. announced positive preliminary results from its Phase...

CRDF : 2.69 (-2.18%)
Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering

CRDF : 2.69 (-2.18%)

Barchart Exclusives

2 Option Ideas To Consider This Tuesday
Today, we are using the stock screener to find stocks with a Buy rating and then looking at a couple of different trade ideas. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades